An insight in Omicron variant and the effectiveness of available vaccines for COVID-19
DOI:
https://doi.org/10.53350/pjmhs22166000Abstract
The Omicron variant (B.1.1.529) recently emerged from South Africa is declared as Variant of Concern (VOCs). More than 30 mutations in the spike proteins were detected, which weaponized the variant with higher transmission rates, a greater affinity for viral binding, and significant antibody escape. COVID-19 vaccines may provide an increase in protection against Omicron by producing more significant levels of neutralising antibodies, still comprehensive clinical data is required.
MeSH words: COVID-19, Omicron, vaccine
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.